Results 131 to 140 of about 649,539 (347)

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola   +14 more
wiley   +1 more source

A Systematic Review of Common Symptoms Associated with Urinary Tract Infections in the Elderly [poster]

open access: yes, 2022
Introduction: Urinary tract infections (UTIs) are a common infection seen in primary care. There are many key predictive factors including age, gender, comorbidities, and symptom presentation that can be used to quickly identify UTIs for rapid treatment ...
Woodall, Lynn
core  

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher   +12 more
wiley   +1 more source

The growing importance of Enterococcus and Streptococcus Agalactiae in uncomplicated urinary tract infections

open access: yes, 2016
Background . Urinary tract infections (UTIs) represent 10-20% of all community-acquired infections. Escherichia coli remains the most commonly isolated microorganism.
Dworniczek, Ewa   +9 more
core   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 CAR‐T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T‐cell therapy in patients with progressive systemic sclerosis. Methods Patients with progressive systemic sclerosis received CD19 CAR‐T cell therapy and were followed longitudinally for safety, clinical efficacy, immune ...
Chenhan Jia   +16 more
wiley   +1 more source

Essential embryology for the Canadian pathologists’ assistant

open access: yesAnatomical Sciences Education, EarlyView.
Abstract Pathologists' assistants (PAs) are pivotal in healthcare, conducting autopsies and examining tissues under a pathologist's guidance. Embryology knowledge is crucial for PAs to accurately assess anomalies and identify pathologies. Yet, it is often overlooked in academic PA training programs.
Samantha H. Nacci   +4 more
wiley   +1 more source

Synergistic Enhancement of Antioxidant Activity in Arbutus unedo Leaf Extract by Biological Fluids: Implications for Functional and Nutraceutical Applications

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT This study examined the effect of biological fluids (saliva, blood plasma, and urine) on the antioxidant capacity of an aqueous extract derived from Arbutus unedo leaves. The extract displayed a concentration‐dependent reducing activity in the ferric reducing power assay (IC50 = 292 ± 7.54 µg/mL) and phosphomolybdenum assays (IC50 = 461.67 ± 4.
Idir Moualek   +6 more
wiley   +1 more source

Implementation of an Antibiotic Stewardship Program for Urinary Tract Infections

open access: yes, 2018
Healthcare-associated infections (HAIs) are associated with increased morbidity, mortality, and excess costs, and because a substantial proportion of HAIs are preventable, they are considered a marker of the quality of patient care (Cassini et al., 2016).
Michel, Kaysha P.
core   +1 more source

Urinary tract infections: epidemiology, mechanisms of infection and treatment options

open access: yesNature Reviews Microbiology, 2015
A. Flores-Mireles   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy